Health technology registries

Evaluating new clinical technology

New Technology section image


In addition to managing six national clinical cardiovascular audits, NICOR is also responsible for providing support for a number of health technology registries. 

We are collecting and analysing data from these new technologies to understand their effectiveness in the treatment of disease.



Left atrial appendage occlusion

The irregular and rapid beating of the atrial chambers of the heart (atrial fibrillation (AF)) increases the risk of stroke. This CtE funded registry aims to collect sufficient data to evaluate the occlusion of the left atrial appendage as a method to prevent stroke in AF patients.

Neuromodulation

The UK Neuromodulation registry collects data on all spinal cord stimulator (SCS), intrathecal drug delivery implant for pain and spasticity (ITDD) and peripheral nerve stimulator (PNS)procedures performed in the UK. 

Percutaneous mitral valve leaflet repair for mitral regurgitation

The mitral valve ensures blood flows from the left atrium into the left ventricle. Mitral regurgitation (MR) occurs when the mitral valve does not close properly, reducing the efficiency of the heart as a pump and leading to heart failure. This CtE funded registry aims to collect sufficient data to evaluate percutaneous mitral valve repair as a method for treating MR.

Patent foramen ovale closure

The foramen ovale is a channel between the atria of the foetal heart, this channel is essential during foetal development. This channel usually closes soon after the lungs become functional after a child is born. However, this is not always the case and some studies have shown adults with patent (open) foramen ovale (PFO) have a higher risk of stroke. This CtE funded registry aims to collect sufficient data to evaluate percutaneous PFO  as a method to prevent stroke in AF patients.

TAVI

Transcatheter Aortic Valve Implantation (TAVI) was first performed in the UK in 2007. The UK TAVI registry has been collecting data to define the characteristics and clinical outcomes of the patient population treated with TAVI in every centre undertaking TAVI.

Page last modified on 25 jun 15 15:17